Identification of novel and rare CYP21A2 variants in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:1
|
作者
Xu, Jing [1 ]
Li, Pin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Endocrinol, Shanghai 200062, Peoples R China
关键词
Congenital adrenal hyperplasia; 21-hydroxylase deficiency; CYP21A2; Variants; GENOTYPE-PHENOTYPE CORRELATION; BRAZILIAN PATIENTS; GENE; MUTATIONS; DIAGNOSIS;
D O I
10.1016/j.clinbiochem.2019.04.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: 21-hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia due to CYP21A2 gene mutation. The aim of study is to expand CYP21A2 mutational spectrum in the Chinese population and to provide novel genetic information in terms of ethnic diversity. Design and methods: 95 Chinese suspected 21-OHD patients with phenotypes varying from salt-wasting (SW) to nonclassic symptoms were recruited. The clinical characteristics were retrospectively analyzed. Sanger sequencing and multiplex ligation-dependent probe amplification were used to detect point mutations and large gene deletions, respectively. Results: 20 different mutant alleles were detected in 35 patients with 21-OHD. The most common variant was c.293-13A/C > G (30.0%), followed by p.I173N (20.0%), large gene conversions (14.3%), large gene deletions (11.4%), and p.R484Pfs*58 (4.3%). Remarkably, we identified a novel F450L variant, in silico predicted to be associated with the salt-wasting form. Two variants including p.R409C and p.R427H, previously considered as conserved in specific ethnicities due to a founder effect, were detected in our cohort. Further, a rare p.H63L + p.V70L variant, hitherto only observed in the Chinese population, in trans with different variants corresponding to the salt-wasting form resulted in diverse phenotypes. Conclusions: One novel and four rare variants of CYP21A2 gene corresponding to severe phenotypes were identified in our cohort. Two variants including p.R409C and p.R427H have wider ethnic distributions. Therefore, the sequence of CYP21A2 gene must be analyzed carefully in case rare or novel deleterious variants exist. Our findings improve the understanding of CYP21A2 mutational spectrum in 21-OHD patients and contribute to the precise diagnosis and prenatal counseling.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 50 条
  • [21] CONGENITAL ADRENAL-HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY
    CUTLER, GB
    ROSEN, H
    BLANKSEGAL, M
    MAJZOUB, J
    LAUE, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (26): : 1806 - 1813
  • [22] Untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Husref Tahirovic
    Alma Toromanovic
    Marina Grubic
    Zorana Grubic
    Katja Dumic
    European Journal of Pediatrics, 2009, 168 : 847 - 849
  • [23] Congenital adrenal hyperplasia in the Bahamas due to 21-hydroxylase deficiency
    Peter, S.
    McDigean, G.
    Sandiford, P.
    Smith, T.
    WEST INDIAN MEDICAL JOURNAL, 2006, 55 (02): : 110 - 112
  • [24] Congenital Adrenal Hyperplasia in Males Due to 21-Hydroxylase Deficiency
    Weniger, M.
    Reisch, N.
    Kuhnle-Krahl, U.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2012, 5 (02): : 16 - 20
  • [25] 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
    Shaw, Amy M.
    NEONATAL NETWORK, 2010, 29 (03): : 191 - 196
  • [26] Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency
    Vrzalova, Zuzana
    Hruba, Zuzana
    Hrabincova, Eva ST'Ahlova
    Pouchla, Slavka
    Votava, Felix
    Kolouskova, Stanislava
    Fajkusova, Lenka
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 (04) : 595 - 603
  • [27] Electroencephalographic changes in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Oliveira, MD
    Gonzales, PH
    Fernandes, MH
    Wolff, H
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1996, 54 (02) : 202 - 206
  • [28] Increased Mortality in Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
    Falhammar, Henrik
    Frisen, Louise
    Norrby, Christina
    Hirschberg, Angelica Linden
    Almqvist, Catarina
    Nordenskjold, Agneta
    Nordenstrom, Anna
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12): : E2715 - E2721
  • [29] Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    冯韵霖
    朱慧娟
    龚凤英
    李乃适
    潘慧
    陆召麟
    史轶蘩
    生殖医学杂志, 2007, (S1) : 16 - 19
  • [30] Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Hoepffner, W
    Herrmann, A
    Willgerodt, H
    Keller, E
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (05): : 705 - 711